Cue Biopharma, Inc.CUENASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank30
3Y CAGR-76.5%
5Y CAGR-60.8%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-76.5%/yr
vs -0.4%/yr prior
5Y CAGR
-60.8%/yr
Recent deceleration
Acceleration
-76.2pp
Decelerating
Percentile
P30
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.05 | -84.1% |
| 2024 | 6.61 | -70.0% |
| 2023 | 22.00 | -73.0% |
| 2022 | 81.61 | +244.6% |
| 2021 | 23.68 | -79.2% |
| 2020 | 113.78 | +12.5% |
| 2019 | 101.18 | +22.2% |
| 2018 | 82.82 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |